Entry

D06714            Crude     Drug

Name

Cassia seed (JP18);
Cassia seed (TN)

Component

Emodin [CPD:C10343], Obtusifolin [CPD:C17039], Obtusin [CPD:C17040], Chryso-obtusin [CPD:C17669], Chryso-obtusin glucoside [CPD:C10313], Aurantio-obtusin [CPD:C17670], Aurantio-obtusin-beta-D-glucoside [CPD:C10303], Rubrofusarin [CPD:C09047], Norrubrofusarin [CPD:C17671], Torachrysone [CPD:C17672], Toralactone [CPD:C17673], Cassiaside B2 [CPD:C17674], Cassiaside C3, Rubrofusarin gentiobioside

Source

Cassia obtusifolia, Cassia tora [TAX:362788], Cassia [TAX:53851]

Remark

Therapeutic category:

5100

Product:

D06714<JP>

Efficacy

Laxative

Comment

Fabaceae (pea family) Cassia seed
Major component: Obtusifolin [CPD:C17039]

Brite

Therapeutic category of drugs in Japan [BR:br08301]
5  Crude drugs and Chinese medicine formulations
  51  Crude drugs
   510  Crude drugs
    5100  Crude drugs
     D06714  Cassia seed (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for digestive organs
  12 Intestinal regulators
   D06714  Cassia seed (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
  Crude drugs
   Cassia seed
    D06714  Cassia seed (JP18)
Traditional Chinese Medicine in Japan [BR:br08304]
Crude drugs
  Purgative drugs
   Purgative drugs
    D06714  Cassia seed
  Drugs for clearing heat
   Drugs for clearing heat
    D06714  Cassia seed; Cassia seed
Crude drugs [BR:br08305]
Dicot plants: rosids
  Fabaceae (pea family)
   D06714  Cassia seed
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
  D06714  Cassia seed

Other DBs

PubChem:

47208365